Conventional Fasting Versus Lipid/Carbohydrate Infusion for Coronary Bypass Patients
Metabolism Disorder
About this trial
This is an interventional prevention trial for Metabolism Disorder focused on measuring perioperative fasting, free fatty acids, coronary bypass grfting
Eligibility Criteria
Inclusion Criteria:
Adult patients (> 18 years) with American Society of Anesthesia (ASA) class II-III, BMI 30-40, and New York Heart Association (NYHA) functional capacities I-II, undergoing elective on-pump coronary artery bypass grafting (CABG) using cardiopulmonary bypass (CPB).
All patients were type 1a World Health Organisation (WHO)/Fredrickson classification of primary hyperlipidemias.
Exclusion Criteria:
- Patients with diabetes mellitus
- Patients on fibrates
- Patients type 1,2b,3,4 and 5 WHO/Fredrickson classification of primary hyperperlipidemias
- Patients with history of allergic reactions to fish, egg yolk containing foods peanut or soy products
- Patients with carbohydrate or fat intolerance
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Glucose group (G group)
Lipid Group (L group)
Control Group (C group)
patients received 500 cc of glucose 10% that containing 50 g of glucose and provides patients with 200 Kcal with 556 mosmoles/L.
patients received 100 cc of lipid solution (soybean 30%, medium chain triglycerides 30%,olive oil 25%,fish oil 15% and 20 mg vitamine E) containing 20 g lipid and provides patients with 200 Kcal with osmolarity of 380 mosmoles /L.
patients was fasting overnight from 11 pm till 9 am except for clear fluids that was allowed till 5 am.